연구동향 분석
박사

Association of plasma level of necroptosis regulators with severity and outcome of sepsis

유홍석 2020년

논문상세정보
인용/피인용
' Association of plasma level of necroptosis regulators with severity and outcome of sepsis' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • biomarker
  • high mobility group box 1
  • necroptosis
  • receptor interactive protein kinase 3
  • sepsis
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
321 0

0.0%

' Association of plasma level of necroptosis regulators with severity and outcome of sepsis' 의 참고문헌

  • Xu Y. RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD
    0.984722222 [2018]
  • Vandenabeele P. RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome
    35 : 908-918 . [2011]
  • Vandenabeele P. Many stimuli pull the necrotic trigger , an overview
    19 : 75-86 . [2012]
  • Toll-like receptor 3-mediated necrosis via TRIF , RIP3 , and MLKL
    288 : 31268-31279 . [2013]
  • TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation
    19 : 2003-2014 . [2012]
  • Serum levels of the apoptosis-associated molecules , tumor necrosis factor-alpha/tumor necrosis factor type-I receptor and Fas/FasL
    125 : 2238-2246 . [2004]
  • Sepsis biomarkers : a review
    14 : R15 . [2010]
  • Samson M. Depletion of RIPK1 in hepatocytes exacerbates liver damage in fulminant viral hepatitis
    0.425 [2019]
  • Ruokonen E. HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis
    34 : 1046-1053 . [2008]
  • RegulatedCell death and inflammation : an auto-amplification loopCauses organ failure
    14 : 759-767 . [2014]
  • Prediction of mortality in adult patients with sepsis using six biomarkers : a systematic review and meta-analysis .
    0.461805556 [2019]
  • New insights into apoptosis signaling by Apo2L/TRAIL .
    29 : 4752-4765 . [2010]
  • Necroptosis : the release of damage-associated molecular patterns and its physiological relevance
    38 : 209-223 . [2013]
  • Necroptosis : a crucial pathogenic mediator of human disease
    4 [2019]
  • Necroptosis : A Novel Cell Death Modality and Its Potential Relevance for Critical Care Medicine
    194 : 415-428 [2016]
  • Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase .
    148 : 213-227 . [2012]
  • Matsuno N. HMGB-1 as a useful prognostic biomarker in sepsis-induced organ failure in patients undergoing PMX-DHP
    171 : 183-190 . [2011]
  • M , Le Gall JR. SAPS 3 -- From evaluation of the patient to evaluation of the intensive care unit . Part 2 : Development of a prognostic model for hospital mortality at
    2005 ; 31 :
  • Late Peaks of HMGB1 and Sepsis Outcome : Evidence For Synergy With Chronic Inflammatory Disorders
    52 : 334-339 . [2019]
  • Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo .
    107 : 270 . [2012]
  • Index for rating diagnostic tests
    3 : 32-35 . [1950]
  • Howrylak JA , Huh JW , Suh GY , Choi AM . Circulating
    mortality and organ
  • High-mobility group box 1 protein plasma concentrations during septic shock
    33 : 1347-1353 . [2007]
  • Han J. RIP3 , an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis
    325 : 332-336 . [2009]
  • HMGB1 as a late mediator of lethal systemic inflammation
    164 : 1768-1773 . [2001]
  • H. Combination of C-reactive protein , procalcitonin and sepsis-related organ failure score for the diagnosis of sepsis in critical patients
    0.285416666666667 [2016]
  • Gauvin F. Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome
    9 : 407-413 . [2008]
  • Finfer S. Recognizing Sepsis as a Global Health Priority -A WHO Resolution
    377 : 414-417 . [2017]
  • Extracellular histones in tissue injury and inflammation
    92 : 465-472 . [2014]
  • Deng X. Soluble tumor necrosis factor related apoptosis inducing ligand level as a predictor of severity of sepsis and the risk of mortality in septic patients
    8 : e82204 . [2013]
  • Cutting edge : RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo
    193 : 1539-1543 . [2014]
  • Circulating high-mobility group box 1 ( HMGB1 ) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis
    35 : 1061-1067 . [2007]
  • Circulating cell death biomarker TRAIL is associated with increased organ dysfunction in sepsis
    4 [2019]
  • Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
    1 : 112-119 . [2005]
  • Aittoniemi J. Apoptosis markers soluble Fas ( sFas ) , Fas Ligand ( FasL ) and sFas/FasL ratio in patients with bacteremia : a prospective cohort study
    64 : 276-281 . [2012]
  • Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis
    343 : 1357-1360 . [2014]
  • APACHE II : a severity of disease classification system
    13 : 818-829 . [1985]
  • 4. Phua J, Koh Y, Du B, Tang YQ, Divatia JV, Tan CC, Gomersall CD, Faruq MO, Shrestha BR, Gia Binh N, Arabi YM, Salahuddin N, Wahyuprajitno B, Tu ML, Wahab AY, Hameed AA, Nishimura M, Procyshyn M, Chan YH, Group MS. Management of severe sepsis in patients admitted to Asian intensive care units: prospective cohort study. BMJ 2011; 342: d3245.
  • 3. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med 2017; 45: 486-552.
  • 27. Shashaty MGS, Reilly JP, Faust HE, Forker CM, Ittner CAG, Zhang PX, Hotz MJ, Fitzgerald D, Yang W, Anderson BJ, Holena DN, Lanken PN, Christie JD, Meyer NJ, Mangalmurti NS. Plasma receptor interacting protein kinase-3 levels are associated with acute respiratory distress syndrome in sepsis and trauma: a cohort study. Crit Care 2019; 23: 235.
  • 25. Newton K, Dugger DL, Maltzman A, Greve JM, Hedehus M, Martin-McNulty B, Carano RA, Cao TC, van Bruggen N, Bernstein L, Lee WP, Wu X, DeVoss J, Zhang J, Jeet S, Peng I, McKenzie BS, Roose-Girma M, Caplazi P, Diehl L, Webster JD, Vucic D. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury. Cell Death Differ 2016; 23: 1565-1576.
  • 21. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22: 707-710.
  • 1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315: 801-810.